Camden Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Camden Capital, LLC

$2.08 Billion
Q4 2025

A detailed history of Camden Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Camden Capital, LLC holds 6,439 shares of VRTX stock, worth $2.79 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

6,439

Previous 5,498 17.12%

Holding current value

$2.79 Million

Previous $2.15 Million 29.77%

% of portfolio

0.13%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 30, 2026	BUY	$402.9 - $437.15 $379,128 - $411,358	941 Added 17.12%	6,439 $2.79 Million
Q3 2025 Nov 13, 2025	BUY	$366.54 - $479.53 $802,356 - $1.05 Million	2,189 Added 66.15%	5,498 $2.15 Million
Q2 2025 Aug 14, 2025	BUY	$421.16 - $509.5 $58,541 - $70,820	139 Added 4.38%	3,309 $1.47 Million
Q1 2025 May 13, 2025	SELL	$402.49 - $513.76 $53,128 - $67,816	-132 Reduced 4.0%	3,170 $1.54 Million
Q4 2024 Jan 29, 2025	SELL	$396.64 - $516.74 $190,387 - $248,035	-480 Reduced 12.69%	3,302 $1.33 Million

Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $339,020 - $372,759	-737 Reduced 16.31%	3,782 $1.76 Million
Q2 2024 Aug 06, 2024	BUY	$392.81 - $485.53 $169,301 - $209,263	431 Added 10.54%	4,519 $2.12 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $614,796 - $672,688	1,508 Added 58.45%	4,088 $1.71 Million
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $148,519 - $177,824	433 Added 20.17%	2,580 $1.05 Million
Q3 2023 Nov 03, 2023	BUY	$338.18 - $362.46 $114,643 - $122,873	339 Added 18.75%	2,147 $746,000
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $258,138 - $288,918	821 Added 83.18%	1,808 $636,000
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $39,935 - $45,557	141 Added 16.67%	987 $310,000
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $770,694 - $867,031	-2,697 Reduced 76.12%	846 $244,000
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $754,127 - $841,429	2,754 Added 349.05%	3,543 $1.03 Million
Q2 2022 Aug 03, 2022	SELL	$234.96 - $292.55 $102,442 - $127,551	-436 Reduced 35.59%	789 $222,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $18,763 - $23,685	106 Added 9.47%	1,225 $269,000
Q3 2021 Nov 03, 2021	SELL	$181.39 - $202.99 $6,530 - $7,307	-36 Reduced 3.12%	1,119 $204,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $4,312 - $5,085	-23 Reduced 1.95%	1,155 $233,000
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $38,919 - $45,366	188 Added 18.99%	1,178 $253,000
Q4 2020 Feb 04, 2021	BUY	$207.01 - $276.09 $204,939 - $273,329	990 New	990 $234,000
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $326,044 - $427,726	-1,446 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$199.77 - $247.81 $6,192 - $7,682	-31 Reduced 2.1%	1,446 $338,000
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $246,230 - $330,715	1,477 New	1,477 $323,000

Others Institutions Holding VRTX

# of Institutions

1,826

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.2M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Vertex Pharmaceuticals Inc Transaction History